{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:51:09Z","timestamp":1773211869215,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T00:00:00Z","timestamp":1343433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00393-011-0925-0","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T16:08:56Z","timestamp":1343318936000},"page":"864-868","source":"Crossref","is-referenced-by-count":13,"title":["An\u00e4mie bei Patienten mit rheumatoider Arthritis","Anemia in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"71","author":[{"given":"M.","family":"Wahle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,28]]},"reference":[{"key":"925_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10067-010-1571-7","volume":"30","author":"Aalto","year":"2011","unstructured":"Aalto K, Honkanen V, Lahdenne P (2011) Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis. Clin Rheumatol 30:115\u2013119","journal-title":"Clin Rheumatol"},{"key":"925_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00277-004-0950-z","volume":"84","author":"Arndt","year":"2005","unstructured":"Arndt U, Kaltwasser JP, Gottschalk R et al (2005) Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Ann Hematol 84:159\u2013166","journal-title":"Ann Hematol"},{"key":"925_CR3","doi-asserted-by":"crossref","unstructured":"Baker JF, Ghio AJ (2009) Iron homoeostasis in rheumatic disease. Rheumatology (Oxford) 48:1339\u20131344","DOI":"10.1093\/rheumatology\/kep221"},{"key":"925_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.beha.2004.08.022","volume":"18","author":"Cook","year":"2005","unstructured":"Cook JD (2005) Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 18:319\u2013332","journal-title":"Best Pract Res Clin Haematol"},{"key":"925_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.52.1.67","volume":"52","author":"Dabbagh","year":"1993","unstructured":"Dabbagh AJ, Trenam CW, Morris CJ et al (1993) Iron in joint inflammation. Ann Rheum Dis 52:67\u201373","journal-title":"Ann Rheum Dis"},{"key":"925_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.48.1578","volume":"48","author":"Demirag","year":"2009","unstructured":"Demirag MD, Haznedaroglu S, Sancak B et al (2009) Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med 48:421\u2013426","journal-title":"Intern Med"},{"key":"925_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semarthrit.2008.08.002","volume":"39","author":"Doyle","year":"2009","unstructured":"Doyle MK, Rahman MU, Han C et al (2009) Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Semin Arthritis Rheum 39:123\u2013131","journal-title":"Semin Arthritis Rheum"},{"key":"925_CR8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/clinids\/5.Supplement_4.S759","volume":"5","author":"Finkelstein","year":"1983","unstructured":"Finkelstein RA, Sciortino CV, Mcintosh MA (1983) Role of iron in microbe-host interactions. Rev Infect Dis 5(Suppl 4):759\u2013777","journal-title":"Rev Infect Dis"},{"key":"925_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","volume":"366","author":"Fleming","year":"2012","unstructured":"Fleming RE, Ponka P (2012) Iron overload in human disease. N Engl J Med 366:348\u2013359","journal-title":"N Engl J Med"},{"key":"925_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pbc.20656","volume":"46","author":"Ganz","year":"2006","unstructured":"Ganz T (2006) Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 46:554\u2013557","journal-title":"Pediatr Blood Cancer"},{"key":"925_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.seminhematol.2009.06.001","volume":"46","author":"Ganz","year":"2009","unstructured":"Ganz T, Nemeth E (2009) Iron sequestration and anemia of inflammation. Semin Hematol 46:387\u2013393","journal-title":"Semin Hematol"},{"key":"925_CR12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.V81.5.1200.1200","volume":"81","author":"Hastka","year":"1993","unstructured":"Hastka J, Lasserre JJ, Schwarzbeck A et al (1993) Zinc protoporphyrin in anemia of chronic disorders. Blood 81:1200\u20131204","journal-title":"Blood"},{"key":"925_CR13","first-page":"2430","volume":"28","author":"Kaltwasser","year":"2001","unstructured":"Kaltwasser JP, Kessler U, Gottschalk R et al (2001) Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 28:2430\u20132436","journal-title":"J Rheumatol"},{"key":"925_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","volume":"17","author":"Macdougall","year":"2002","unstructured":"Macdougall IC, Cooper AC (2002) Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17(Suppl 11):39\u201343","journal-title":"Nephrol Dial Transplant"},{"key":"925_CR15","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3748\/wjg.15.4617","volume":"15","author":"Munoz","year":"2009","unstructured":"Munoz M, Villar I, Garcia-Erce JA (2009) An update on iron physiology. World J Gastroenterol 15:4617\u20134626","journal-title":"World J Gastroenterol"},{"key":"925_CR16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271\u20131276","journal-title":"J Clin Invest"},{"key":"925_CR17","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J et al (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090\u20132093","journal-title":"Science"},{"key":"925_CR18","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"Park","year":"2001","unstructured":"Park CH, Valore EV, Waring AJ et al (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806\u20137810","journal-title":"J Biol Chem"},{"key":"925_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.55.3.162","volume":"55","author":"Peeters","year":"1996","unstructured":"Peeters HR, Jongen-Lavrencic M, Raja AN et al (1996) Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 55:162\u2013168","journal-title":"Ann Rheum Dis"},{"key":"925_CR20","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2005-06-2259","volume":"107","author":"Peyssonnaux","year":"2006","unstructured":"Peyssonnaux C, Zinkernagel AS, Datta V et al (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107:3727\u20133732","journal-title":"Blood"},{"key":"925_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2567.2009.03226.x","volume":"130","author":"Pinto","year":"2010","unstructured":"Pinto JP, Dias V, Zoller H et al (2010) Hepcidin messenger RNA expression in human lymphocytes. Immunology 130:217\u2013230","journal-title":"Immunology"},{"key":"925_CR22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V89.3.1052","volume":"89","author":"Punnonen","year":"1997","unstructured":"Punnonen K, Irjala K, Rajamaki A (1997) Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89:1052\u20131057","journal-title":"Blood"},{"key":"925_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.semarthrit.2008.01.006","volume":"38","author":"Raj","year":"2009","unstructured":"Raj DS (2009) Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 38:382\u2013388","journal-title":"Semin Arthritis Rheum"},{"key":"925_CR24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"Smolen","year":"2008","unstructured":"Smolen JS, Beaulieu A, Rubbert-Roth A et al (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987\u2013997","journal-title":"Lancet"},{"key":"925_CR25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1189\/jlb.1208719","volume":"86","author":"Sow","year":"2009","unstructured":"Sow FB, Alvarez GR, Gross RP et al (2009) Role of STAT1, NF-kappaB, and C\/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J Leukoc Biol 86:1247\u20131258","journal-title":"J Leukoc Biol"},{"key":"925_CR26","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/art.30623","volume":"63","author":"Van","year":"2011","unstructured":"Van Santen S, Van Dongen-Lases EC, De Vegt F et al (2011) Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 63:3672\u20133680","journal-title":"Arthritis Rheum"},{"key":"925_CR27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352:1011\u20131023","journal-title":"N Engl J Med"},{"key":"925_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2003.12.012","volume":"116","author":"Wilson","year":"2004","unstructured":"Wilson A, Yu HT, Goodnough LT et al (2004) Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 116(Suppl 7A):50\u201357","journal-title":"Am J Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0925-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-011-0925-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0925-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T13:38:26Z","timestamp":1594474706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-011-0925-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,28]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1007\/s00393-011-0925-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,28]]}}}